Detalhe da pesquisa
1.
MicroRNAs as a clue to overcome breast cancer treatment resistance.
Cancer Metastasis Rev
; 41(1): 77-105, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34524579
2.
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835014
3.
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.
Int J Mol Sci
; 23(21)2022 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362083
4.
Synthesis of 2-aminopropyl benzopyran derivatives as potential agents against triple-negative breast cancer.
RSC Med Chem
; 14(11): 2327-2341, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020071
5.
Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies.
Cancers (Basel)
; 15(18)2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760491
6.
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.
Cancers (Basel)
; 15(7)2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046799